Investor Centre
Medigard was established in 1999 and listed on the Australian Stock Exchange in February 2004. The directors and executives have extensive business and commercialisation experience at senior levels and are supported by an award winning design and production team.
PUBLICATIONS, ANNOUNCEMENTS & REPORTS
AnnUAL rEporT 2011
To read or download the Medigard Annual report 2011 please click here.
AnnUAL rEporT 2010
To read or download the Medigard Annual report 2010 please click here.
AnnUAL rEporT 2009
To read or download the Medigard Annual report 2009 please click here.
AnnUAL rEporT 2008
To read or download the Medigard Annual report 2008 please click here.
AnnUAL rEporT 2007
To read or download the Medigard Annual report 2007 please click here.
AnnUAL rEporT 2006
To read or download the Medigard Annual report 2006 please click here.
AnnUAL rEporT 2005
To read or download the Medigard Annual report 2005 please click here.
AnnUAL rEporT 2004
To read or download the Medigard Annual report 2004 please click here.
ANNOUNCEMENTS
JAN 2012
Appendix 4c - Quarterly 30th Jan 2012
NOV 2011
Results of Meeting 21st Nov 2011
NOV 2011
Chairman's Address to Shareholders 21st Nov 2011
OCT 2011
Appendix 4C 25th Oct 2011
OCT 2011
Notice of Meeting and Proxy 21st Oct 2011
SEP 2011
Annual Statutory Accounts Report 28th Sep 2011
AUG 2011
Preliminary Final Report Appendix 4E 31st Aug 2011
JUL 2011
Appendix 4C 29th Jul 2011
JUN 2011
Expiry of Options 30th Jun 2011
APR 2011
Appendix 4C 29th Apr 2011
APR 2011
Resignation as Executive 18th Apr 2011
MAR 2011
Company Secretary Appointment - Resignation 22nd Mar 2011
MAR 2011
Appendix 3B Incentive Options 2nd Mar 2011
FEB 2011
Half-Yearly Report and Accounts 24th Feb 2011
FEB 2011
Notice of Resignation CEO & Company Secretary 24th Feb 2011
FEB 2011
Boardroom Radio Announcement 2nd Feb 2011
FEB 2011
Patent Announcement for BCD (Japanese) and 1ml Syringe 1st Feb 2011
JAN 2011
Appendix 4C - Quarterly 28th Jan 2011
DEC 2010
Updated Trading Policy 31st Dec 2010
NOV 2010
Boardroom Radio Announcement 24th Nov 2010
NOV 2010
Results of Meeting 24th Nov 2010
NOV 2010
Chairman's Address to Shareholders 23rd Nov 2010
NOV 2010
Change of Director's Interest Notice Appendix 4B 16th Nov 2010
NOV 2010
Shortfall Application and Appendix 3B 16th Nov 2010
OCT 2010
Appendix 4C 28th Oct 2010
OCT 2010
Shortfall Application & Appendix 3B 19th Oct 2010
OCT 2010
Notice of Meeting and Proxy 13th Oct 2010
SEP 2010
Grant of Patent in South Africa 21st Sep 2010
SEP 2010
Change of Director's Interest Notice Appendix 3Y 2nd Sep 2010
SEP 2010
Change of Director's Interest Notice Appendix 3Y 2nd Sep 2010
AUG 2010
Preliminary Final Report Appendix 3E 31st Aug 2010
AUG 2010
Completion Rights Issue and Appendix 3B 30th Aug 2010
AUG 2010
Boardroom Radio Announcement 20th Aug 2010
AUG 2010
Investor Presentations
AUG 2010
Despatch of Prospectus and Letter to Shareholders
AUG 2010
Letter to Shareholders
AUG 2010
Supplementary Prospectus
AUG 2010
Market Announcement
AUG 2010
Boardroom Radio Announcement 3rd Aug 2010
JUL 2010
Medigard letter to Shareholders
JUL 2010
Medigard announces Rights Issue to support US expansion
MAY 2010
Medigard expands into the US
MAY 2010
Replacement and updated appendix 3B
APR 2010
Quarterly report for the period ending 31 March, 2010
APR 2010
Application for quotation of additional securities and agreement
APR 2010
Medigard 3mL safety retractable syringe - clinical trials results
MAR 2010
Application for quotation of additional securities and agreement
MAR 2010
Marketing - retractable syringe product evaluation
FEB 2010
Half yearly announcement
JAN 2010
Quarterly report for the period ending 31 December, 2009
DEC 2009
Medigard signs US manufacturer
NOV 2009
Confirmation of resolutions passed at annual general meeting
NOV 2009
Annual general meeting presentations
SEP 2009
Quarterly report for entities admitted on the basis of commitments
SEP 2009
Annual statutory accounts year ended 30 June, 2009
SEP 2009
Letter to shareholders
REPORTS
AUG 2009
Results for announcement
JUN 2009
Quarterly report
JUN 2009
Expiry of options
APR 2009
Change of director’s interest
APR 2009
Change of director’s interest
APR 2009
Change of director’s interest
APR 2009
Change of director’s interest
APR 2009
Loyalty bonus options
APR 2009
Prospectus lodges with ASIC
APR 2009
Completion of SPP
MAR 2009
Quarterly report
Presentation AUG 2010
To read or download Medigard’s AUG 2010 presentation including product overviews, information on the medical device market and opportunities available please click here.
Medigard will offer existing shareholders 74,046,091 new shares at an issue price of 6.5 cents. As part of the offer, each new share will have an attached option, exercisable at 9.5 cents on or before 30 June 2011. The offer opens on 10 August 2010 and closes on 25 August 2010. Trading of Rights will commence on the ASX on 30 July 2010 and cease on 18 August 2010. New shares are expected to commence trading on 2 September 2010. To download the prospectus click here.
To view Medigard’s (MGZ) current share price.Click here